Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medicus Pharma Ltd V.MDCX

Alternate Symbol(s):  MDCX | MDCXW

Healthcare Biotechnology
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:MDCX)

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

GlobeNewswire 13 days ago

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

GlobeNewswire December 2, 2024

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

GlobeNewswire November 18, 2024

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Newsfile November 15, 2024

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Newsfile November 13, 2024

Canadian Investment Regulatory Organization Trade Resumption - MDCX

Canada NewsWire October 28, 2024

Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing

Newsfile October 28, 2024

Canadian Investment Regulatory Organization Trading Halt - MDCX

Canada NewsWire October 25, 2024

Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults

Newsfile August 27, 2024
View More News ››

Opinion & Analysis (TSXV:MDCX)

Medicus Pharma advances cancer treatment towards phase II trial

Ryan Dhillon January 22, 2024

Zacks Small-Cap Research initiates coverage of Medicus Pharma (TSXV:MDCX)

Research January 10, 2024
View More Opinion ››

Bullboard Posts (TSXV:MDCX)

New interview with CEO Bokhari

https://stockhouse.com/news/press-releases/2024/12/12/medicus-pharma-ltd-announces-minor-use-mums-designation-from-the-fda-for
Jolly09 - 6 days ago

NASDAQ Listing

I think the share consolidation and uplisting to NASDAQ is the right move.  https://stockhouse.com/news/press-releases/2024/11...
Jolly09 - November 13, 2024

Ackers Bioscience Another Company Raza Bokhari involved

https://www.globenewswire.com/news-release/2015/11/12/786555/29748/en/Akers-Biosciences-Appoints-Dr-Raza-Bokhari-as-Non-executive...
LingMai2024 - June 28, 2024

Raza Bokhari Hired Steven Buyer - Who was charged by SEC

Also note While Raza Bokhari was the CEO of FSD Pharma he had hired Steven Buyer https://www.newswire.ca/news-releases/fsd-pharma...
LingMai2024 - June 28, 2024

Todays News Release FSD Pharma Vs Raza Bokhari Lawsuit

The recent news about FSD Pharma winning a final judgment against former CEO Raza Bokhari is highly significant for shareholders for...
LingMai2024 - June 28, 2024

MDCX CEO Raza Bokahri Owes FSD Pharma Shareholders Millions

These legal awards are owing to FSD Pharma and it's shareholders by the current chairman and CEO of Medicus Pharma Dr. Raza Bokhari...
LingMai2024 - May 31, 2024
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical ...
View More »